Prevention of Aortic Valve Fusion
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 12/394,185, filed Feb 27, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,046,098 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| US 10,376,622 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| US 12,083,330 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| US 9,687,596 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| US 8,562,507 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| US 11,648,386 | Prevention of Aortic Valve Fusion In force · High confidence | TC1 LLC | In force | High confidence | ||
| Application 18/813,461 | Prevention of Aortic Valve Fusion Pending Not granted | TC1 LLC | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by TC1 LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.